Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:22 PM
Ignite Modification Date:
2025-12-24 @ 12:22 PM
NCT ID:
NCT01702961
Eligibility Criteria:
Inclusion Criteria:
* Patients with biopsy-proven, relapsed, or refractory CD20+ lymphoma, or HD.
* At least 2e6 CD34+/kg autologous PBSC stored. If patients are non-mobilizers, then at least 2e8 TNC/kg autologous marrow should be stored.
* Patient is not pregnant.
* Zubrod performance status less than or equal to 2.
* Life expectancy is not severely limited by concomitant illness.
* Left ventricular ejection fraction greater than or equal to 50%.
* No uncontrolled arrhythmias or symptomatic cardiac disease.
* FEV1, FVC and DLCO greater than or equal to 50%.
* No symptomatic pulmonary disease.
* Serum creatinine less than or equal to 1.5 mg/dL.
* Serum bilirubin less than or equal to 2X upper limit of normal, SGPT less than or equal to 3X upper limit of normal.
* No evidence of chronic active hepatitis or cirrhosis.
* No effusion or ascites greater than or equal to 1L prior to drainage.
* HIV negative.
* Patient or guardian able to sign informed consent.
* Patients of any age may be enrolled on this protocol.
Exclusion Criteria:
* Anyone not meeting the above criteria.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT01702961
Study Brief:
Protocol Section:
NCT01702961